Running a clinical trial in more than one country can help sponsors reach a wider patient population and collect data from different markets. However, it also makes the regulatory process more complex. 

Each country may follow its own rules, review procedures, document requirements, and ethics approval process. A regulatory submission that is accepted in one market may need changes before it can be submitted in another. 

Therefore, sponsors need a clear plan before starting the submission process. Strong coordination, accurate documentation, local knowledge, and consistent communication can help reduce delays and support a smoother clinical trial start-up. 

Understand the Regulatory Requirements of Each Country 

The first step in a multi-country clinical trial is understanding the requirements of every country involved. 

Different countries may have different: 

• Regulatory authorities  

• Submission portals  

• Application forms  

• Review procedures  

• Document requirements  

• Language requirements  

• Ethics committee processes  

Sponsors should not assume that one submission package can be used in exactly the same way everywhere. 

A clear country-by-country requirements list can help teams understand what needs to be prepared before the regulatory submission begins. 

This is also where experienced regulatory submission services can be useful. Regulatory teams with local market knowledge can help identify specific requirements and reduce the risk of incomplete submissions. 

Build a Clear Global Regulatory Strategy 

A multi-country trial needs more than separate submissions for different markets. It needs one overall strategy. 

The regulatory strategy should define: 

• Which countries will be included? 

• Which markets will be prioritised? 

• Whether submissions will happen together or in phases? 

• Who will manage each country submission?  

• How documents and updates will be controlled?  

• How will communication happen across teams? 

For example, some sponsors may decide to submit in all target countries at the same time. Others may begin with only a few countries initially and expand later. 

There is no single approach that works for every study. The right strategy depends on the trial design, target patient population, study timelines, internal resources, and country requirements. 

Strong planning is especially important for global regulatory submissions, where delays in one country can affect wider study timelines. 

Prepare a Strong Core Submission Package 

A well-prepared core package creates a strong foundation for multi-country submissions. 

The exact requirements may vary, but common regulatory submission documents can include: 

• Clinical trial protocol  

• Investigator’s Brochure  

• Informed consent documents  

• Information about the investigational product  

• Safety information  

• Sponsor details  

• Investigator and site information  

• Supporting administrative documents  

The core documents should be accurate, complete, and consistent before country-specific adaptations begin. 

This helps reduce the risk of different teams working with different versions of the same document. 

For example, if the protocol is updated during preparation, all country teams should know which version is current. Using an outdated protocol in one market can create unnecessary questions or delays. 

Manage Country-Specific Documentation 

Even with a strong global package, many documents may need to be adapted for individual countries. 

Country-specific requirements may include: 

• Local application forms  

• Translated documents  

• Local informed consent forms  

• Insurance documents  

• Site-specific information  

• Local legal documents  

• Administrative declarations  

• Country-specific patient materials  

The regulatory affairs submission process should therefore include enough time for local adaptation. 

Translations are especially important. A document should not only be translated accurately. It should also be clear and understandable for the intended audience. 

Patient-facing materials may need additional review to make sure the language is appropriate and easy to understand. 

Coordinate Regulatory and Ethics Committee Submissions 

Clinical trials often require review by both regulatory authorities and ethics committees. 

These reviews may not work in the same way in every country. 

In some markets, regulatory and ethics reviews may happen in parallel. In others, one approval may need to come before another step can begin. 

The submission team should understand: 

• Which bodies need to review the study  

• What documents each body requires  

• Whether submissions can happen together  

• Whether different versions of documents are needed  

• How approvals and communications will be tracked  

Good coordination is important because regulatory and ethics submissions often involve overlapping documents. 

For example, an informed consent form may be part of both processes. If one version is updated, the team needs to make sure the correct version is used everywhere. 

Maintain Consistency Across All Countries 

Consistency is one of the most important parts of a multi-country regulatory submission. 

Core study information should remain aligned across all markets unless a local requirement makes a change necessary. 

Teams should carefully manage: 

• Protocol versions  

• Investigator’s Brochure versions  

• Informed consent forms  

• Safety information  

• Application forms  

• Supporting documents  

Version control is essential. 

Without a central process, one country may receive an older document while another receives the latest version. This can lead to questions, additional work, and confusion across the study team. 

A simple version tracking system can show:

Document	Current Version	Countries Submitted	Update Needed
Protocol	Version 3.0	India, UK, Australia	No
Investigator’s Brochure	Version 5.0	All countries	No
Consent Form	Country-specific	Varies	Review locally

A central system also makes it easier to identify which countries need to receive future updates. 

Consider Local Language and Cultural Requirements 

Language is not only a translation issue. It is also an important part of communication with patients, sites, ethics committees, and local authorities. 

Patient information should be understandable in the local language and suitable for the local population. 

This may apply to: 

• Informed consent forms  

• Patient diaries  

• Recruitment materials  

• Participant instructions  

• Study questionnaires  

Literal translation may not always be enough. 

Some words or phrases may need to be adapted so that the meaning remains clear. Cultural differences may also affect how information is presented. 

For this reason, sponsors should allow enough time for translation, review, correction, and final approval. 

Poorly prepared translations can slow down global regulatory submissions, especially when documents need to be revised and resubmitted. 

Use Centralised Tracking and Regulatory Technology 

Managing multiple countries through emails and separate spreadsheets can quickly become difficult. 

A centralised tracking system can help teams monitor the complete regulatory affairs submission process. 

The system may track: 

• Submission dates  

• Current status  

• Approval dates  

• Document versions  

• Country requirements  

• Pending actions  

• Renewals  

• Communication history  

The goal is not simply to use more technology. The goal is to create visibility. 

Work With Experienced Local and Global Teams 

Multi-country clinical trials require both global coordination and local understanding. 

A central team may manage the overall strategy, but local experts can help interpret country-specific requirements and support communication with local stakeholders. 

Responsibilities should be clearly defined between: 

• The sponsor  

• The CRO  

• Global regulatory teams  

• Local regulatory specialists  

• Study sites  

Experienced regulatory submission services can also support document preparation, local adaptation, submission coordination, and tracking. 

The key is to avoid duplication and confusion. Every team member should know what they are responsible for and when their input is required. 

Best CRO in India for Multi-Country Clinical Trial 

Looking for a CRO that can help you with global submissions? Check out Innovate Research. Our approach is simple. We take the time to understand each client’s needs in depth and carefully assess their regulatory requirements. Here are the countries we cater to:  

Through advance planning and rigorous execution of regulatory filings in compliance with the relevant regulatory authorities, we provide timely, up-to-date global regulatory support that helps our clients stay ahead. 

Our other services include medical writing, clinical site management, biospecimen collection, Pharmacovigilence, data management, and more.  

We also have branches in 5 different countries including India, the USA, the UAE, UK, and Hungary. Connect with us TODAY! 

Conclusion 

A multi-country clinical trial creates opportunities, but it also adds complexity to the regulatory submission process. 

Sponsors need to manage different local requirements while keeping the overall study information accurate and consistent. A strong core document package, clear country-specific planning, effective version control, and close coordination between global and local teams can make the process easier to manage. 

For global regulatory submissions, early preparation is especially important. Delays often happen when local requirements are identified too late, documents are inconsistent, or responsibilities are unclear. 

Visit Innovate Research to learn more about our services. 

FAQs 

1. What is a regulatory submission in clinical trials?

A regulatory submission is the process of providing clinical trial documents and study information to the relevant regulatory authorities for review and approval.

2. What documents are usuallyrequiredfor a regulatory submission? 

Common regulatory submission documents may include the clinical trial protocol, Investigator’s Brochure, informed consent forms, safety information, investigator details, and supporting administrative documents.

3. Why are global regulatory submissions more complex?

Global regulatory submissions are more complex because each country may have different regulatory requirements, timelines, submission portals, language needs, and ethics review procedures.

4. How can regulatory submission services support multi-country trials?

Regulatory submission services can help with document preparation, country-specific requirements, submission coordination, local adaptations, tracking, and communication with different regulatory teams.

5. What is the regulatory affairs submission process?

The regulatory affairs submission process usually includes regulatory planning, document preparation, country-specific adaptation, submission to authorities, tracking, and managing any required updates or follow-up actions.